Literature DB >> 26353035

Second-generation ALK inhibitors.

Hiroyuki Mano1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26353035

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  3 in total

1.  Recurrent fusion of the genes FN1 and ALK in gastrointestinal leiomyomas.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Marius Lund-Iversen; Ingvild Lobmaier; Bodil Bjerkehagen; Sverre Heim
Journal:  Mod Pathol       Date:  2016-07-29       Impact factor: 7.842

Review 2.  Interstitial Deletions Generating Fusion Genes.

Authors:  Ioannis Panagopoulos; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2021 May-Jun       Impact factor: 4.069

3.  Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and mice.

Authors:  Joachim T Siaw; Haiying Wan; Kathrin Pfeifer; Victor M Rivera; Jikui Guan; Ruth H Palmer; Bengt Hallberg
Journal:  Oncotarget       Date:  2016-05-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.